Antitubercular therapy (ATT) induced hepatotoxicity, although well known to clinicians, is
often over looked and underrated. Given the low threshold of starting ATT, especially …

Background: Tuberculosis (TB) is a very common droplet infection especially in the northern
areas. If untreated, the disease may be fatal within 5 years in more than half of cases. To …

The linchpin of tuberculosis eradication is the anti-tuberculous drugs (ATD) predominantly
isoniazid, rifampicin, pyrazinamide and ethambutol. The major adverse effects of ATD is …

Tuberculosis is one of the world's health problems, especially in developing countries.
Treatment regimen with multiple first-line anti-tuberculosis drugs (ATD) such as Isoniazid …

Abstract Drug-Induced Liver Injury (DILI) from Anti-Tuberculosis Therapy (ATT) is
increasingly common and affects patient outcomes. Factors like alcohol use, existing liver …

Background: Incidence of Antitubercular Therapy (ATT)-induced hepatotoxicity is higher in
India when compared to Western countries. As the occurrence of ATT-induced hepatotoxicity …

Drug-induced liver injury is the common adverse effect seen in patients receiving
antituberculosis drugs (ATDs). There are several risk factors associated with the …

Tuberculosis is a potentially communicable disease that can infect any organ in the body
such as bones, kidney, intestine but primarily involves lung parenchyma (Pulmonary …

Background Antituberculosis treatment (ATT) induced hepato-toxicity is common, but risk
factors predicting its development are poorly understood. The present study evaluates the …

Hepatotoxicity is an emerging medical problem. It has multiple etiological factors but most
common reason is chronic treatment with certain drugs during the cure of numerous life …